New AI Model Predicts Cancer Outcomes from Tissue Samples
Researchers at UT Southwestern Medical Center developed a novel AI model that analyzes the spatial arrangement of cells in tissue samples.
Read More
Search Results for: lung cancer
Exai Bio’s RNA-Based Liquid Biopsy Platform Detects Early Stage Breast Cancer Accurately
Exai Bio’s liquid biopsy platform can detect breast cancer at the earliest stages and the smallest tumor sizes using a standard blood sample.
Read More
UCLA Receives $9M to Improve Early Cancer Detection
UCLA Researchers received $9.1 million in grant funding from the National Cancer Institute to advance liquid biopsy tech for cancer detection.
Read More
Personalis and Tempus Collaborate to Advance Cancer Testing
Personalis and Tempus Labs announced a collaboration to co-commercialize a whole genome-based liquid biopsy LDT for MRD and cancer detection.
Read More
Veracyte’s Nasal Swab Test Gets Clinical Validation for Lung Cancer Risk Assessment
Clinical validation data shows that Veracyte’s Percepta Nasal Swab test determines lung cancer risk with high accuracy for certain patients.
Read More